PubMed · 7455019
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
U Schulz, M Busch, E Scherer. 1980. [Optimized interstitial radiogold therapy (author's transl)].. https://pubmed.ncbi.nlm.nih.gov/7455019/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Biopsy of the first tumour-draining lymph node (sentinel node, SN) is bound to become the procedure of choice in regional staging of melanoma and breast cancer patients. Several radiopharmaceuticals have been developed for lymphoscintigraphy. In this paper we review the most frequently used radiopharmaceuticals for their appropriateness in the sentinel-node procedure. We conclude that accurate localization of SNs is demonstrated using technetium-99m-sulfur colloid (99mTc-SC), 99mTc antimony trisulfide colloid (99mTc-ATC) [10] and 99mTc nanocolloidal albumin (99mTc-CA). 99mTc-Ca and 99mTc-SC are both available in Europe. In the United States 99mTc-SC is the only registered tracer for lymphoscintigraphy.
Explore the source record for details and available documents.
Explore the source record for details and available documents.